We are live on
!
Find out more
WM
WS Management Portfolio holdings
AUM
$1.13B
1-Year Est. Return
53.44%
This Fund
S&P 500
This Quarter
Est. Return
-18.88%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.23B
AUM Growth
-$810M
(-40%)
Cap. Flow
-$536M
Cap. Flow
% of AUM
-43.53%
Top 10 Holdings %
Top 10 Hldgs %
62.76%
Holding
91
New
21
Increased
12
Reduced
15
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$29.8M |
| 2 |
Micron Technology
MU
|
+$19.2M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$12.8M |
| 4 |
Apple
AAPL
|
+$10.6M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$8.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$40.5M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$14M |
| 3 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$10.5M |
| 4 |
Marathon Petroleum
MPC
|
+$4.67M |
| 5 |
PPLI
People Inc
PPLI
|
+$3.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.41% |
| 2 | Technology | 6.81% |
| 3 | Materials | 5.82% |
| 4 | Consumer Staples | 3.88% |
| 5 | Energy | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLLS
76
Cellectis
CLLS
$291M
| $144K | 0.01% |
50,907
| – | – |
|
|
BLUE
77
DELISTED
bluebird bio
BLUE
| $46K | ﹤0.01% |
561
| – | – |
|
78
Abeona Therapeutics
ABEO
$349M
| $19K | ﹤0.01% |
3,696
| – | – |
|
|
GOEV
79
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $8K | ﹤0.01% |
+9
| New | +$15.8K |
|
80
Angi Inc
ANGI
$240M
| – | – |
-51,472
| Closed | -$2.92M |
|
81
Baidu
BIDU
$35.8B
| – | – |
-16,200
| Closed | -$2.14M |
|
82
CALL
Chewy
CHWY
$8.93B
| – | – |
-70,000
| Closed | -$2.85M |
|
|
83
PUT
Chewy
CHWY
$8.93B
| – | – |
-100,000
| Closed | -$4.08M |
|
|
PPLI
84
People Inc
PPLI
$3.15B
| – | – |
-44,815
| Closed | -$3.69M |
|
85
JD.com
JD
$41.8B
| – | – |
-39,600
| Closed | -$2.29M |
|
|
86
PUT
Micron Technology
MU
$1.02T
| – | – |
-250,000
| Closed | -$19.5M |
|
87
CALL
Newmont
NEM
$98.5B
| – | – |
-150,000
| Closed | -$11.9M |
|
|
88
PUT
Newmont
NEM
$98.5B
| – | – |
-100,000
| Closed | -$7.95M |
|
89
PUT
Teladoc Health
TDOC
$1.61B
| – | – |
-80,000
| Closed | -$5.77M |
|
90
CALL
Uber
UBER
$139B
| – | – |
-100,000
| Closed | -$3.57M |
|
|
HMHC
91
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| – | – |
-500,000
| Closed | -$10.5M |
|
Similar funds
OHIF
HMCP
SAM
AT
ACM
IP
PFCS
PL
WS Management's Q2 2022 Portfolio in Review
As of Q2 2022, WS Management held 91 positions worth $1.23B, down 40% from $2.04B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
WS Management withdrew a net $536M in Q2 2022, closing 12 positions and reducing 15 holdings. Its most notable exit was Houghton Mifflin Harcourt Company, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 7.3% a quarter earlier, followed by Technology and Materials.
Against the trend, WS Management opened a new position in State Street SPDR S&P Biotech ETF worth $12.6M.
- WS Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 170,000 shares worth $12.6M.
- WS Management added most to Berkshire Hathaway Class B in Q2 2022, an estimated $29.8M increase.
- WS Management's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $40.5M.
- WS Management fully exited Houghton Mifflin Harcourt Company in Q2 2022, selling an estimated $10.5M.
- WS Management's ten largest holdings make up 63% of its $1.23B portfolio in Q2 2022.
- WS Management opened 21 new positions and closed 12 in Q2 2022.
- WS Management's portfolio value fell 40% quarter-over-quarter to $1.23B.
Based on WS Management's 13F filing for Q2 2022, filed 15 Aug 2022.